Amped PCR
PrivateLast Round
Grant
May 9, 2025
Total Funding Raised
$1.58M
Company Overview
Amped PCR operates in Healthcare & Life Sciences and is based in Aberystwyth. Its latest recorded funding round was a Grant round in May 2025.
Amped PCR is a biotechnology company that manufactures high-performance PCR reagents and develops PurifAI, an automated, deployable laboratory system for rapid pathogen detection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring, Business Intelligence
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amped PCR Comparables
Compare Amped PCR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alveo Technologies | 78% | |
| LuminUltra | 74% | |
| GeneReach Biotechnology Corp. | 73% |
For institutional investors. Book with your work email.
Amped PCR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 9, 2025 | ||||
| Seed | Dec 16, 2024 | ||||
| Grant | Oct 1, 2024 | ||||
| Pre Seed | Apr 5, 2024 | ||||
| Grant | Oct 2, 2023 | ||||
Accelerator | Jul 6, 2022 |
For institutional investors. Book with your work email.
Amped PCR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SFC Capital | Seed, Pre Seed |
| Welsh Government | Grant |
| Development Bank of Wales | Seed, Pre Seed |
| Ministry of Housing, Communities and Local Government | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 2138% MoM, from 37 to 828.
- Dec 3, 2025
Added Scan.com Corporation, a healthcare technology SMB, as a customer.
For institutional investors. Book with your work email.
Amped PCR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amped PCR's valuation, stock price, and market status.
Is Amped PCR a public or private company?
Amped PCR is a private company.
What is the current stock price of Amped PCR?
Amped PCR is a private company, so its shares have no public market price. Caplight tracks Amped PCR's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amped PCR worth (valuation)?
Valuation information for Amped PCR is not publicly available.
Can I buy Amped PCR stock?
Amped PCR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amped PCR's last funding round?
Amped PCR's most recent funding round was Grant on May 9, 2025.
Who are the main investors in Amped PCR?
Key investors in Amped PCR include SFC Capital, Welsh Government, Development Bank of Wales, Ministry of Housing, Communities and Local Government.
Will Amped PCR IPO soon?
No public IPO plans have been announced for Amped PCR.
How can I track Amped PCR secondary market activity?
Caplight tracks bids, offers, and trades in Amped PCR's shares on secondary markets.